Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care

NCT05257031 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Nutrition Therapy
Critical Illness

Interventions

DRUG: SmofKabiven extra Nitrogen

Sponsor

Fresenius Kabi